Long-term Efficacy of Lerodalcibep in 1,468 Patients at Very High and High Risk for CVD in the 72 week Open-Label Extension Trial

Access
info:eu-repo/semantics/closedAccessDate
2024Author
Kereiakes, DeanFourie, Nyda
Scott, Russell
Asprusten, Emil
Yalim, Zafer
Vest, Jeff
Kallend, David
Metadata
Show full item recordAbstract
[Abstract Not Available]















